Pharmaceutical

Star Therapeutics raises $90m in funding to advance antibody therapies

The Series C funding will support the clinical advancement of Vega Therapeutics’ antibody candidate for treating von Willebrand disease.

Sep 5, 2023 - 20:00
Star Therapeutics raises $90m in funding to advance antibody therapies
The Series C funding will support the clinical advancement of Vega Therapeutics’ antibody candidate for treating von Willebrand disease.
Read the original article

Tags:

Previous Article

Direct oral anticoagulants’ positive effects on cancer-associated VTE

Next Article

Launching pharmaceuticals in the Nordics: Opportunities and challenges

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Medicare official insists drug price negotiation will consider value of drugs

STAT+: Medicare official insists drug price negotiation...

Apr 25, 2023

Long Covid research funding at NIH gets a nearly 50% boost

Long Covid research funding at NIH gets a nearly 50% boost

Feb 15, 2024

Results from Rybrevant trial solidify Janssen’s foothold in EGFR-mutated NSCLC

Results from Rybrevant trial solidify Janssen’s foothol...

Sep 13, 2023